Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Guzman-Fulgencio, M; Berenguer, J; Garcia-Alvarez, M; Fernandez-Rodriguez, A; Jimenez-Sousa, MA; Alvarez, E; Micheloud, D; Lopez, JC; Miralles, P; Cosin, J; Catalan, P; Resino, S.

IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus

JOURNAL OF INFECTION. 2013; 66(2): 170-178 Nº de citas: 15 [doi:10.1016/j.jinf.2012.10.025]

Fernandez-Rodriguez, A; Rallon, N; Berenguer, J; Jimenez-Sousa, MA; Cosin, J; Guzman-Fulgencio, M; Restrepo, C; Lopez, JC; Garcia-Alvarez, M; Miralles, P; Soriano, V; Benito, JM; Resino, S.

Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients

AIDS. 2013; 27(2): 163-173 Nº de citas: 10 [doi:10.1097/QAD.0b013e32835c11e8]

Masia, M; Padilla, S; Alvarez, D; Lopez, JC; Santos, I; Soriano, V; Hernandez-Quero, J; Santos, J; Tural, C; del Amo, J; Gutierrez, F.

Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy

AIDS. 2013; 27(2): 181-189 Nº de citas: 51 [doi:10.1097/QAD.0b013e32835a1156]

Garcia-Alvarez, M; Berenguer, J; Guzman-Fulgencio, M; Alvarez, E; Cosin, J; Micheloud, D; Jimenez-Sousa, MA; Fernandez-Rodriguez, A; Aldamiz-Echevarria, T; Carrero, A; Miralles, P; Resino, S.

Bacterial DNA Translocation and Liver Disease Severity Among HIV-Infected Patients With Chronic Hepatitis C

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2012; 61(5): 552-556 Nº de citas: 12 [doi:10.1097/QAI.0b013e31826ea109]

Martinez, E; D'Albuquerque, PM; Llibre, JM; Gutierrez, F; Podzamczer, D; Antela, A; Berenguer, J; Domingo, P; Moreno, X; Perez, I; Pich, J; Gatell, JM.

Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir

AIDS. 2012; 26(18): 2315-2326 Nº de citas: 117 [doi:10.1097/QAD.0b013e328359f29c]

Berenguer, J; Alejos, B; Hernando, V; Viciana, P; Salavert, M; Santos, I; Gomez-Sirvent, JL; Vidal, F; Portilla, J; Del Amo, J.

Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy

AIDS. 2012; 26(17): 2241-2246 Nº de citas: 37 [doi:10.1097/QAD.0b013e3283574e94]

Suarez-Lozano, I; Domingo, P; Lozano, F; Viciana, P; Lopez-Aldeguer, J; Terron, A; Munoz-Sanchez, J; Galindo, MJ; Cosin, J; Geijo, P; Ribera, E; Roca, B; Sanchez, T; Munoz-Sanz, A; de la Puente, B; Deig, E; Vergara, A; Vidal, F; Pedrol, E; Teira, R; Estrada, V; Castano, M; Puig, T; Garrido, M.

Budget impact analysis of antiretroviral therapy. A reflection based on the GESIDA guidelines

Gaceta Sanitaria. 2012; 26(6): 541-546 Nº de citas: 3 [doi:10.1016/j.gaceta.2012.01.015]

Resino, S; Sanchez-Conde, M; Berenguer, J.

Coinfection by human immunodeficiency virus and hepatitis C virus: noninvasive assessment and staging of fibrosis

CURRENT OPINION IN INFECTIOUS DISEASES. 2012; 25(5): 564-569 Nº de citas: 30 [doi:10.1097/QCO.0b013e32835635df]

Macias, J; Berenguer, J; Japon, MA; Giron-Gonzalez, JA; Rivero, A; Lopez-Cortes, LF; Moreno, A; Marquez, M; Iribarren, JA; Ortega, E; Miralles, P; Merchante, N; Pineda, JA.

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients

HEPATOLOGY. 2012; 56(4): 1261-1270 Nº de citas: 42 [doi:10.1002/hep.25791]

Labarga, P; Barreiro, P; da Silva, A; Guardiola, JM; Rubio, R; Aguirrebengoa, K; Miralles, P; Portu, J; Tellez, MJ; Morano, L; Castro, A; Pineda, JA; Terron, A; Hernandez-Quero, J; Marino, A; Rios, MJ; Echeverria, S; Asensi, V; Vispo, E; Soriano, V.

Comparison of High Ribavirin Induction Versus Standard Ribavirin Dosing, Plus Peginterferon-alpha for the Treatment of Chronic Hepatitis C in HIV-Infected Patients: The PERICO Trial

JOURNAL OF INFECTIOUS DISEASES. 2012; 206(6): 961-968 Nº de citas: 16 [doi:10.1093/infdis/jis449]

Ramirez, MLM; Pascual-Pareja, JF; Sanchez-Conde, M; De la Serna, JIB; Vargas, FXZ; Miralles, P; Castro, JM; Ramirez, M; Gutierrez, I; Gonzalez-Garcia, J; Berenguer, J; Lopez, JRA.

Transient elastography to rule out esophageal varices and portal hypertensive gastropathy in HIV-infected individuals with liver cirrhosis

AIDS. 2012; 26(14): 1807-1812 Nº de citas: 13 [doi:10.1097/QAD.0b013e3283573267]

Hernando, V; Sobrino-Vegas, P; Burriel, MC; Berenguer, J; Navarro, G; Santos, I; Reparaz, J; Martinez, MA; Antela, A; Gutierrez, F; del Amo, J.

Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms

AIDS. 2012; 26(14): 1829-1834 Nº de citas: 27 [doi:10.1097/QAD.0b013e328352ada4]

Podzamczer, D; Tiraboschi, JM; Mallolas, J; Curto, J; Cardenes, MA; Casas, E; Castro, A; Echevarria, S; Leal, M; de Quiros, JCLB; Moreno, S; Puig, T; Ribera, E; Villalonga, C; Gomez-Sirvent, JL; Garcia-Henarejos, JA; Lopez-Aldeguer, J; Barrufet, P; Force, L; Santos, I; Sanz, J.

Long-Term Benefits of Nevirapine-Containing Regimens: Multicenter Study with 506 Patients, Followed-Up a Median of 9 Years

CURRENT HIV RESEARCH. 2012; 10(6): 513-520 Nº de citas: 5 [doi:10.2174/157016212802429820]

Berenguer, J; Rodriguez, E; Miralles, P; Von Wichmann, MA; Lopez-Aldeguer, J; Mallolas, J; Galindo, MJ; Van Den Eynde, E; Tellez, MJ; Quereda, C; Jou, A; Sanz, J; Barros, C; Santos, I; Pulido, F; Guardiola, JM; Ortega, E; Rubio, R; Jusdado, JJ; Montes, ML; Gaspar, G; Esteban, H; Bellon, JM; Gonzalez-Garcia, J.

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

CLINICAL INFECTIOUS DISEASES. 2012; 55(5): 728-736 Nº de citas: 149 [doi:10.1093/cid/cis500]

Blanco, JR; Jarrin, I; Vallejo, M; Berenguer, J; Solera, C; Rubio, R; Pulido, F; Asensi, V; del Amo, J; Moreno, S.

Definition of Advanced Age in HIV Infection: Looking for an Age Cut-Off

AIDS RESEARCH AND HUMAN RETROVIRUSES. 2012; 28(9): 800-806 Nº de citas: 78 [doi:10.1089/aid.2011.0377]

Gastaca, M; Aguero, F; Rimola, A; Montejo, M; Miralles, P; Lozano, R; Castells, L; Abradelo, M; de la Mata, M; Rodriguez, FS; Cordero, E; del Campo, S; Manzardo, C; de Urbina, JO; Perez, I; de la Rosa, G; Miro, JM.

Liver Retransplantation in HIV-Infected Patients: A Prospective Cohort Study

AMERICAN JOURNAL OF TRANSPLANTATION. 2012; 12(9): 2465-2476 Nº de citas: 8 [doi:10.1111/j.1600-6143.2012.04142.x]

Miro, JM; Montejo, M; Castells, L; Rafecas, A; Moreno, S; Aguero, F; Abradelo, M; Miralles, P; Torre-Cisneros, J; Pedreira, JD; Cordero, E; de la Rosa, G; Moyano, B; Moreno, A; Perez, I; Rimola, A.

Outcome of HCV/HIV-Coinfected Liver Transplant Recipients: A Prospective and Multicenter Cohort Study

AMERICAN JOURNAL OF TRANSPLANTATION. 2012; 12(7): 1866-1876 Nº de citas: 122 [doi:10.1111/j.1600-6143.2012.04028.x]

Blasco, AJ; Arribas, JR; Boix, V; Clotet, B; Domingo, P; Gonzalez-Garcia, J; Knobel, H; Lopez, JC; Llibre, JM; Lozano, F; Miro, JM; Podzamczer, D; Santamaria, JM; Tuset, M; Zamora, L; Lazaro, P; Gatell, JM.

Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National plan for AIDS for the initial antiretroviral therapy in adult human Immunodeficiency virus (HIV) infected patients in 2012

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2012; 30(6): 283-293 Nº de citas: 14 [doi:10.1016/j.eimc.2012.02.016]